Next |
home / stock / adgi / adgi message board
Subject | By | Source | When |
---|---|---|---|
Lets gooooo$$$ | INFINITI | investorshub | 03/30/2022 3:34:33 PM |
Let her run geez | INFINITI | investorshub | 03/30/2022 3:06:31 PM |
Going to burst mark it $$$ | INFINITI | investorshub | 03/30/2022 2:52:43 PM |
On watch | Penny chatter | investorshub | 03/30/2022 2:50:23 PM |
Possible | Penny chatter | investorshub | 03/30/2022 2:49:59 PM |
Im in looks good lets gooo | INFINITI | investorshub | 03/30/2022 2:34:19 PM |
Short SQUEEZE and HALT on the menu today. | November61 | investorshub | 03/30/2022 1:00:02 PM |
Can it test previous price zones? | jchords | investorshub | 03/30/2022 12:42:35 PM |
https://finviz.com/quote.ashx?t=$ADGI | TheFinalCD | investorshub | 03/30/2022 11:49:44 AM |
Adagio Therapeutics Announces ADG20 (adintrevimab) is the First | Awl416 | investorshub | 03/30/2022 11:20:58 AM |
Is not a data read out coming this month? | Tim696969 | investorshub | 03/14/2022 3:49:21 PM |
Not really! Antibodies direction is a solution that | November61 | investorshub | 02/22/2022 2:56:34 PM |
Novavax announced approval in Canada just last week | double_m | investorshub | 02/22/2022 1:24:01 PM |
This stock is so freaking disappointing! A whole | double_m | investorshub | 02/11/2022 10:52:25 PM |
Looking nice here ;-) $ADGI $$$$ | Man6677 | investorshub | 02/08/2022 8:30:45 AM |
SQUEEZE and FILL the Gaps! | November61 | investorshub | 02/07/2022 5:15:11 PM |
Bought more at 5.80. Confident on that one. | November61 | investorshub | 01/21/2022 9:15:08 PM |
Very good ! Thanks . | Man6677 | investorshub | 01/20/2022 3:18:16 PM |
January 16th: Listed on NASDAQ.com as one of | Disquisition | investorshub | 01/17/2022 1:19:57 AM |
Very disappointing today after the news . | Man6677 | investorshub | 01/13/2022 5:56:24 PM |
News, Short Squeeze, Breakout and More Instantly...
Adagio Therapeutics Inc. Company Name:
ADGI Stock Symbol:
NASDAQ Market:
WALTHAM, Mass., May 13, 2024 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today announced that Marc Elia, Chairman of the Invivyd Board of Directors, is scheduled to present in a fireside cha...
Launched PEMGARDA™ in the U.S. for COVID-19 pre-exposure prophylaxis (PrEP) in certain adults and adolescents with moderate-to-severe immune compromise Reported interim exploratory COVID-19 clinical event data from CANOPY Phase 3 clinical trial of VYD222 Received product-sp...
Pathway leverages immunobridging approach via serum virus neutralizing antibody (sVNA) titers enabled by prior successful COVID-19 treatment clinical trial “STAMP” conducted with prototype antibody adintrevimab Company anticipates submitting a COVID-19 treatment EUA applicat...